European Lithium Directors Cash In Options at Steep Discount as Merger Clock Winds Down

Directors buy at A$0.08 vs market A$0.31; merger with Critical Metals faces vote, court, and regulatory hurdles.

The gap between what European Lithium's board pays for shares and what the market charges for them has rarely been wider. Several directors exercised options at 0.08 Australian dollars apiece in late July, a strike price that sits at roughly a quarter of the stock's recent trading level on the ASX. The transactions, disclosed via Appendix 3Y filings on 24 July, are a routine feature of long-dated incentive schemes — but their timing, coming just weeks before shareholders vote on the company's merger with Critical Metals Corp, puts the spotlight back on the deal's final stretch.

A Tale of Two Markets

The divergence between the stock's two trading venues tells its own story. On the Australian exchange, the shares climbed 5.76 percent to 0.31 Australian dollars between 8 and 10 August, extending a five-day winning streak to 13.46 percent. Frankfurt has been far more subdued: the stock changed hands at 0.1898 euros, essentially flat on the day, though it has still managed a 5.33 percent advance over seven sessions. That leaves the German listing roughly 38 percent below its 52-week high of 0.3055 euros — a gap that suggests the recent bounce owes more to catching up with Sydney than to any fresh momentum.

Tuesday's session reinforced the cautious tone, with the shares slipping 1.68 percent to 0.1868 euros. The distance from the early-June peak has now stretched to 38.85 percent.

The Balance Sheet Behind the Deal

The quarterly report filed on 31 July, alongside the Appendix 5B cash-flow statement, revealed a war chest of 296.3 million Australian dollars as of 30 June. More telling is what sits on the asset side: European Lithium already holds 45,536,338 shares in its future parent. At a price of 6.04 US dollars per CRML share on 28 July, that stake was worth roughly 275 million US dollars — a bridging position that gives the company meaningful financial firepower while the merger works its way through the remaining approvals.

Neither the cash-flow statement nor the quarterly update flagged any material outflows or capital raisings, suggesting the balance sheet remains intact as the transaction enters its decisive phase.

One Chairman, Two Companies

Not everyone is entirely comfortable with the governance setup. Tony Sage chairs both European Lithium and Critical Metals, a dual role that has drawn scrutiny from observers even though the transaction requires independent approvals. For retail holders weighing their vote, the arrangement is a reminder that the same person sits atop both sides of the table — a point worth considering even if the deal's economics remain unchanged.

What's Left Before the Finish Line

The merger is far from a foregone conclusion. Beyond the shareholder vote, the scheme requires approval from an Australian court and a series of regulatory clearances. Any one of those hurdles could delay or derail the targeted completion in the second half of 2026, with the shareholder meetings pencilled in for late August and implementation slated for September.

The structure itself carries an additional layer of complexity. With the exchange ratio fixed at 0.035 Critical Metals shares for each European Lithium share, the ultimate value delivered to European shareholders hinges on two variables entirely outside the company's control: the Nasdaq price of CRML and the Australian dollar–US dollar exchange rate.

The amended Scheme Implementation Deed, signed over a month ago, addressed mostly technical mechanics — scrapping the CDI structure and introducing a sale facility for holders with fewer than 50,000 shares. The economic heart of the deal was left untouched, yet the stock has still shed roughly 20.3 percent since that announcement, a reminder that even unchanged deal terms can see their market value drift.

Meanwhile, institutional positioning continues. Weiss Asset Management confirmed on 4 August that it holds a 5.06 percent voting stake via 87,349,781 ordinary shares, a position first established in late July. Bank of America had already disclosed a holding back in January.

For investors, the directors' option exercise is a small but telling signal that those closest to the company see value at the current level. The real test, however, comes at the ballot box — and in the Nasdaq trading screens that will ultimately determine what this merger is worth.